Rational inhalation therapy in COPD in India: Hope or hype!
1 Associate Professor& Head, Pulmonary Medicine, MIMSR Medical college & Venkatesh Hospital, Latur, Maharashtra, India.
2 Assistant Professor, Pharmacology, Vilasrao Deshmukh Government Medical college, Latur, Maharashtra, India.
Review
World Journal of Advanced Pharmaceutical and Life Sciences, 2023, 04(01), 001–004.
Article DOI: 10.53346/wjapls.2023.4.1.0053
Publication history:
Received on 04 January 2023; revised on 18 February 2023; accepted on 21 February 2023
Abstract:
Chronic obstructive pulmonary disease (COPD) is common chronic lung disease usually treated in all health care settings as per knowledge of disease, availability of medicines and affordability of patients in India. COPD is second leading cause of death in list of all cause of mortality. COPD is under evaluated and half-heartedly treated with irrational oral medicines in spite of rational inhalation therapy in primary to tertiary care settings. More than half of the cases died due to cardiovascular causes are having underlying COPD as precipitating factor. More disease awareness regarding use of spirometry in health care professionals for proper diagnosis of COPD with more emphasis on rational inhalation treatment is must to prevent morbidity of mortality of this treatable disease.
Keywords:
COPD; Rational Inhalation therapy; Spirometry; Oral Medicines; Awareness
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0